Selenium Status in Diet Affects Nephrotoxicity Induced by Cisplatin in Mice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selenium Status in Diet Affects Nephrotoxicity Induced by Cisplatin in Mice
Authors
Keywords
-
Journal
Antioxidants
Volume 11, Issue 6, Pages 1141
Publisher
MDPI AG
Online
2022-06-10
DOI
10.3390/antiox11061141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The renoprotective effects of gallic acid on cisplatin-induced nephrotoxicity through anti-apoptosis, anti-inflammatory effects, and downregulation of lncRNA TUG1
- (2022) Negin Amini et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade
- (2021) Rehab M. El-Sayed et al. LIFE SCIENCES
- Regression Modeling of the Antioxidant-to-Nephroprotective Relation Shows the Pivotal Role of Oxidative Stress in Cisplatin Nephrotoxicity
- (2021) Alfredo G. Casanova et al. Antioxidants
- Transcriptomic analysis of rat kidney reveals a potential mechanism of sex differences in susceptibility to cisplatin-induced nephrotoxicity
- (2021) Da-Bin Hwang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study
- (2021) Akira Ohkoshi et al. ORAL ONCOLOGY
- Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury
- (2020) Ping Cheng et al. BIOCHEMICAL PHARMACOLOGY
- Selenium and selenoproteins: it’s role in regulation of inflammation
- (2020) Sneha Hariharan et al. INFLAMMOPHARMACOLOGY
- Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study
- (2020) Wiem Ben Ayed et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Selenium Status in Diet Affects Acetaminophen-Induced Hepatotoxicity via Interruption of Redox Environment
- (2020) Jing Li et al. ANTIOXIDANTS & REDOX SIGNALING
- Protective effects of nucleosides‐rich extract from Cordyceps cicadae against cisplatin induced testicular damage
- (2020) Ling Wang et al. CHEMISTRY & BIODIVERSITY
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer
- (2019) Yasuhide Yamada et al. CANCER SCIENCE
- Advances in Toxicological Research of the Anticancer Drug Cisplatin
- (2019) Luyu Qi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Facile synthesis of antioxidative nanotherapeutics using a microwave for efficient reversal of cisplatin-induced nephrotoxicity
- (2019) Haoqiang Lai et al. CHEMICAL ENGINEERING JOURNAL
- Selenium – a fascinating antioxidant of protective properties
- (2018) Małgorzata Kiełczykowska et al. Advances in Clinical and Experimental Medicine
- Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation
- (2018) Chen Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Daphnetin protects against cisplatin-induced nephrotoxicity by inhibiting inflammatory and oxidative response
- (2018) Lina Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mouse population-based evaluation of urinary protein and miRNA biomarker performance associated with cisplatin renal injury
- (2017) Alison H Harrill et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
- (2015) Primož Strojan et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
- (2014) A. R. de Biasi et al. CLINICAL CANCER RESEARCH
- Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review
- (2014) P.D. Marcato et al. CURRENT CANCER DRUG TARGETS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The thioredoxin antioxidant system
- (2013) Jun Lu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Functionalized selenium nanoparticles with nephroprotective activity, the important roles of ROS-mediated signaling pathways
- (2013) Yinghua Li et al. Journal of Materials Chemistry B
- Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose
- (2012) Yatao Du et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selenium, selenoproteins and the thyroid gland: interactions in health and disease
- (2011) Lutz Schomburg Nature Reviews Endocrinology
- Activation of NRF2 by Nitrosative Agents and H2O2Involves KEAP1 Disulfide Formation
- (2010) Simon Fourquet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selenium and Selenoproteins in Health and Disease
- (2009) Laura V. Papp et al. ANTIOXIDANTS & REDOX SIGNALING
- Comparison Between the Effects of 2-Selenium Bridged β-Cyclodextrin and Ebselen on Treating SHRsp Stroke
- (2008) Z JIA et al. CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
- Cisplatin: a review of toxicities and therapeutic applications
- (2008) K. Barabas et al. Veterinary and Comparative Oncology
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search